APO Research
Talk to an analyst

APO RESEARCH · REPORT

Agomelatine API

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Agomelatine API Market Outlook and Growth Opportunities 2026

23 December 2025199 pages

Choose your research edition.

Industry ResearchAgomelatine API Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Agomelatine API Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Agomelatine API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Agomelatine API Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Agomelatine API Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Agomelatine API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Agomelatine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Agomelatine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Agomelatine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Agomelatine API market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Agomelatine API market include Msn Pharmachem Private Ltd, Jiangsu Hansoh Pharmaceutical Group and Yangtze River Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Agomelatine API market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Agomelatine API and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Agomelatine API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Agomelatine API market size, projected growth trends, production technologies, key applications, and end-use industries.

Agomelatine API Segment by Company

Msn Pharmachem Private Ltd

Jiangsu Hansoh Pharmaceutical Group

Yangtze River Pharmaceutical

Agomelatine API Segment by Type

Purity ≥99%

98%≤purity≤99%

Agomelatine API Segment by Application

Tablets

Others

Agomelatine API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Agomelatine API status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Agomelatine API market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Agomelatine API significant trends, drivers, influence factors in global and regions.

6. To analyze Agomelatine API competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Agomelatine API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Agomelatine API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Agomelatine API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Agomelatine API market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Agomelatine API industry.

Chapter 3: Detailed analysis of Agomelatine API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Agomelatine API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Agomelatine API in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Agomelatine API Industry Trends Table 2. Agomelatine API Industry Drivers Table 3. Agomelatine API Industry Opportunities and Challenges Table 4. Agomelatine API Industry Restraints Table 5. Global Agomelatine API Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Agomelatine API Revenue Share by Company (2021-2026) Table 7. Global Agomelatine API Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Agomelatine API Sales Volume Share by Company (2021-2026) Table 9. Global Agomelatine API Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Agomelatine API Company Ranking, (2024-2026) & (USD Million) Table 11. Global Agomelatine API Key Company Manufacturing Base & Headquarters Table 12. Global Agomelatine API Company, Product Type & Application Table 13. Global Agomelatine API Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Agomelatine API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Purity ≥99% Table 18. Significant Companies of 98%≤purity≤99% Table 19. Global Agomelatine API Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 20. Global Agomelatine API Sales Volume by Type (2021-2026) & (Tons) Table 21. Global Agomelatine API Sales Volume by Type (2027-2032) & (Tons) Table 22. Global Agomelatine API Sales Volume Share by Type (2021-2026) Table 23. Global Agomelatine API Sales Volume Share by Type (2027-2032) Table 24. Global Agomelatine API Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Agomelatine API Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Agomelatine API Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Agomelatine API Sales Value Share by Type (2021-2026) Table 28. Global Agomelatine API Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Tablets Table 30. Significant Companies of Others Table 31. Global Agomelatine API Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 32. Global Agomelatine API Sales Volume by Application (2021-2026) & (Tons) Table 33. Global Agomelatine API Sales Volume by Application (2027-2032) & (Tons) Table 34. Global Agomelatine API Sales Volume Share by Application (2021-2026) Table 35. Global Agomelatine API Sales Volume Share by Application (2027-2032) Table 36. Global Agomelatine API Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Agomelatine API Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Agomelatine API Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Agomelatine API Sales Value Share by Application (2021-2026) Table 40. Global Agomelatine API Sales Value Share by Application (2027-2032) Table 41. Global Agomelatine API Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 42. Global Agomelatine API Sales by Region (2021-2026) & (Tons) Table 43. Global Agomelatine API Sales Market Share by Region (2021-2026) Table 44. Global Agomelatine API Sales by Region (2027-2032) & (Tons) Table 45. Global Agomelatine API Sales Market Share by Region (2027-2032) Table 46. Global Agomelatine API Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Agomelatine API Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Agomelatine API Sales Value Share by Region (2021-2026) Table 49. Global Agomelatine API Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Agomelatine API Sales Value Share by Region (2027-2032) Table 51. Global Agomelatine API Market Average Price (US$/Ton) by Region (2021-2026) Table 52. Global Agomelatine API Market Average Price (US$/Ton) by Region (2027-2032) Table 53. Global Agomelatine API Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 54. Global Agomelatine API Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Agomelatine API Sales by Country (2021-2026) & (Tons) Table 56. Global Agomelatine API Sales Market Share by Country (2021-2026) Table 57. Global Agomelatine API Sales by Country (2027-2032) & (Tons) Table 58. Global Agomelatine API Sales Market Share by Country (2027-2032) Table 59. Global Agomelatine API Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Agomelatine API Sales Value Market Share by Country (2021-2026) Table 61. Global Agomelatine API Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Agomelatine API Sales Value Market Share by Country (2027-2032) Table 63. Msn Pharmachem Private Ltd Company Information Table 64. Msn Pharmachem Private Ltd Business Overview Table 65. Msn Pharmachem Private Ltd Agomelatine API Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 66. Msn Pharmachem Private Ltd Agomelatine API Product Portfolio Table 67. Msn Pharmachem Private Ltd Recent Development Table 68. Jiangsu Hansoh Pharmaceutical Group Company Information Table 69. Jiangsu Hansoh Pharmaceutical Group Business Overview Table 70. Jiangsu Hansoh Pharmaceutical Group Agomelatine API Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 71. Jiangsu Hansoh Pharmaceutical Group Agomelatine API Product Portfolio Table 72. Jiangsu Hansoh Pharmaceutical Group Recent Development Table 73. Yangtze River Pharmaceutical Company Information Table 74. Yangtze River Pharmaceutical Business Overview Table 75. Yangtze River Pharmaceutical Agomelatine API Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Yangtze River Pharmaceutical Agomelatine API Product Portfolio Table 77. Yangtze River Pharmaceutical Recent Development Table 78. Key Raw Materials Table 79. Raw Materials Key Suppliers Table 80. Agomelatine API Distributors List Table 81. Agomelatine API Customers List Table 82. Research Programs/Design for This Report Table 83. Authors List of This Report Table 84. Secondary Sources Table 85. Primary Sources List of Figures Figure 1. Agomelatine API Product Image Figure 2. Global Agomelatine API Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Agomelatine API Sales Value (2021-2032) & (US$ Million) Figure 4. Global Agomelatine API Sales (2021-2032) & (Tons) Figure 5. Global Agomelatine API Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Agomelatine API Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Purity ≥99% Image Figure 10. 98%≤purity≤99% Image Figure 11. Global Agomelatine API Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 12. Global Agomelatine API Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Agomelatine API Sales Volume Share by Type (2021-2032) Figure 14. Global Agomelatine API Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Agomelatine API Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Agomelatine API Sales Value Share by Type (2021-2032) Figure 17. Tablets Image Figure 18. Others Image Figure 19. Global Agomelatine API Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 20. Global Agomelatine API Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Agomelatine API Sales Volume Share by Application (2021-2032) Figure 22. Global Agomelatine API Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Agomelatine API Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Agomelatine API Sales Value Share by Application (2021-2032) Figure 25. Global Agomelatine API Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 26. Global Agomelatine API Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Agomelatine API Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Agomelatine API Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Agomelatine API Sales Value (2021-2032) & (US$ Million) Figure 30. North America Agomelatine API Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Agomelatine API Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Agomelatine API Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Agomelatine API Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Agomelatine API Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Agomelatine API Sales Value (2021-2032) & (US$ Million) Figure 36. South America Agomelatine API Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Agomelatine API Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Agomelatine API Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Agomelatine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Agomelatine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Agomelatine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Agomelatine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Agomelatine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Agomelatine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Agomelatine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Agomelatine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Agomelatine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Agomelatine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Agomelatine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Agomelatine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Agomelatine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Agomelatine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Agomelatine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Agomelatine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Agomelatine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Agomelatine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Agomelatine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Agomelatine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Agomelatine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Agomelatine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Agomelatine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Agomelatine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Agomelatine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Agomelatine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Agomelatine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Agomelatine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Agomelatine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Agomelatine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Agomelatine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Agomelatine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Agomelatine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Agomelatine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Agomelatine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Agomelatine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Agomelatine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Agomelatine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Agomelatine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Agomelatine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Agomelatine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Agomelatine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Agomelatine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Agomelatine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Agomelatine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Agomelatine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Agomelatine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Agomelatine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Agomelatine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Agomelatine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Agomelatine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Agomelatine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Agomelatine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Agomelatine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Agomelatine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Agomelatine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Agomelatine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Agomelatine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Agomelatine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Agomelatine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Agomelatine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Agomelatine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Agomelatine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Agomelatine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Agomelatine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Agomelatine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Agomelatine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Agomelatine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Agomelatine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Agomelatine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Agomelatine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Agomelatine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Agomelatine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Agomelatine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Agomelatine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Agomelatine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Agomelatine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Agomelatine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Agomelatine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Agomelatine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Agomelatine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Agomelatine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Agomelatine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Agomelatine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Agomelatine API Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Agomelatine API Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Purity ≥99%
  • 98%≤purity≤99%
Applications
  • Tablets
  • Others
Companies covered
  • Msn Pharmachem Private Ltd
  • Jiangsu Hansoh Pharmaceutical Group
  • Yangtze River Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Agomelatine API Sales Value (2021-2032)
  4. 1.2.2 Global Agomelatine API Sales Volume (2021-2032)
  5. 1.2.3 Global Agomelatine API Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Agomelatine API Market Dynamics
  1. 2.1 Agomelatine API Industry Trends
  2. 2.2 Agomelatine API Industry Drivers
  3. 2.3 Agomelatine API Industry Opportunities and Challenges
  4. 2.4 Agomelatine API Industry Restraints
3 Agomelatine API Market by Company
  1. 3.1 Global Agomelatine API Company Revenue Ranking in 2025
  2. 3.2 Global Agomelatine API Revenue by Company (2021-2026)
  3. 3.3 Global Agomelatine API Sales Volume by Company (2021-2026)
  4. 3.4 Global Agomelatine API Average Price by Company (2021-2026)
  5. 3.5 Global Agomelatine API Company Ranking (2024-2026)
  6. 3.6 Global Agomelatine API Company Manufacturing Base and Headquarters
  7. 3.7 Global Agomelatine API Company Product Type and Application
  8. 3.8 Global Agomelatine API Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Agomelatine API Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Agomelatine API Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Agomelatine API Market by Type
  1. 4.1 Agomelatine API Type Introduction
  2. 4.1.1 Purity ≥99%
  3. 4.1.2 98%≤purity≤99%
  4. 4.2 Global Agomelatine API Sales Volume by Type
  5. 4.2.1 Global Agomelatine API Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Agomelatine API Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Agomelatine API Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Agomelatine API Sales Value by Type
  9. 4.3.1 Global Agomelatine API Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Agomelatine API Sales Value by Type (2021-2032)
  11. 4.3.3 Global Agomelatine API Sales Value Share by Type (2021-2032)
5 Agomelatine API Market by Application
  1. 5.1 Agomelatine API Application Introduction
  2. 5.1.1 Tablets
  3. 5.1.2 Others
  4. 5.2 Global Agomelatine API Sales Volume by Application
  5. 5.2.1 Global Agomelatine API Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Agomelatine API Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Agomelatine API Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Agomelatine API Sales Value by Application
  9. 5.3.1 Global Agomelatine API Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Agomelatine API Sales Value by Application (2021-2032)
  11. 5.3.3 Global Agomelatine API Sales Value Share by Application (2021-2032)
6 Agomelatine API Regional Sales and Value Analysis
  1. 6.1 Global Agomelatine API Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Agomelatine API Sales by Region (2021-2032)
  3. 6.2.1 Global Agomelatine API Sales by Region: 2021-2026
  4. 6.2.2 Global Agomelatine API Sales by Region (2027-2032)
  5. 6.3 Global Agomelatine API Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Agomelatine API Sales Value by Region (2021-2032)
  7. 6.4.1 Global Agomelatine API Sales Value by Region: 2021-2026
  8. 6.4.2 Global Agomelatine API Sales Value by Region (2027-2032)
  9. 6.5 Global Agomelatine API Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Agomelatine API Sales Value (2021-2032)
  12. 6.6.2 North America Agomelatine API Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Agomelatine API Sales Value (2021-2032)
  15. 6.7.2 Europe Agomelatine API Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Agomelatine API Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Agomelatine API Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Agomelatine API Sales Value (2021-2032)
  21. 6.9.2 South America Agomelatine API Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Agomelatine API Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Agomelatine API Sales Value Share by Country, 2025 VS 2032
7 Agomelatine API Country-level Sales and Value Analysis
  1. 7.1 Global Agomelatine API Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Agomelatine API Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Agomelatine API Sales by Country (2021-2032)
  4. 7.3.1 Global Agomelatine API Sales by Country (2021-2026)
  5. 7.3.2 Global Agomelatine API Sales by Country (2027-2032)
  6. 7.4 Global Agomelatine API Sales Value by Country (2021-2032)
  7. 7.4.1 Global Agomelatine API Sales Value by Country (2021-2026)
  8. 7.4.2 Global Agomelatine API Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Agomelatine API Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Agomelatine API Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Agomelatine API Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Agomelatine API Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Agomelatine API Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Agomelatine API Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Agomelatine API Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Agomelatine API Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Agomelatine API Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Agomelatine API Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Agomelatine API Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Agomelatine API Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Agomelatine API Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Agomelatine API Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Agomelatine API Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Agomelatine API Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Agomelatine API Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Agomelatine API Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Agomelatine API Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Agomelatine API Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Agomelatine API Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Agomelatine API Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Agomelatine API Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Agomelatine API Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Agomelatine API Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Agomelatine API Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Agomelatine API Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Agomelatine API Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Agomelatine API Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Agomelatine API Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Agomelatine API Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Agomelatine API Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Agomelatine API Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Agomelatine API Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Agomelatine API Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Agomelatine API Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Agomelatine API Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Agomelatine API Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Agomelatine API Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Agomelatine API Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Agomelatine API Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Agomelatine API Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Agomelatine API Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Agomelatine API Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Agomelatine API Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Agomelatine API Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Agomelatine API Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Agomelatine API Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Agomelatine API Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Agomelatine API Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Agomelatine API Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Agomelatine API Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Agomelatine API Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Agomelatine API Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Agomelatine API Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Agomelatine API Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Agomelatine API Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Agomelatine API Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Agomelatine API Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Agomelatine API Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Agomelatine API Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Agomelatine API Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Agomelatine API Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Agomelatine API Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Agomelatine API Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Agomelatine API Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Agomelatine API Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Agomelatine API Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Agomelatine API Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Agomelatine API Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Agomelatine API Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Agomelatine API Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Agomelatine API Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Agomelatine API Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Agomelatine API Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Agomelatine API Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Agomelatine API Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Agomelatine API Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Agomelatine API Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Agomelatine API Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Agomelatine API Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Agomelatine API Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Agomelatine API Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Agomelatine API Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Msn Pharmachem Private Ltd
  2. 8.1.1 Msn Pharmachem Private Ltd Company Information
  3. 8.1.2 Msn Pharmachem Private Ltd Business Overview
  4. 8.1.3 Msn Pharmachem Private Ltd Agomelatine API Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Msn Pharmachem Private Ltd Agomelatine API Product Portfolio
  6. 8.1.5 Msn Pharmachem Private Ltd Recent Developments
  7. 8.2 Jiangsu Hansoh Pharmaceutical Group
  8. 8.2.1 Jiangsu Hansoh Pharmaceutical Group Company Information
  9. 8.2.2 Jiangsu Hansoh Pharmaceutical Group Business Overview
  10. 8.2.3 Jiangsu Hansoh Pharmaceutical Group Agomelatine API Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Jiangsu Hansoh Pharmaceutical Group Agomelatine API Product Portfolio
  12. 8.2.5 Jiangsu Hansoh Pharmaceutical Group Recent Developments
  13. 8.3 Yangtze River Pharmaceutical
  14. 8.3.1 Yangtze River Pharmaceutical Company Information
  15. 8.3.2 Yangtze River Pharmaceutical Business Overview
  16. 8.3.3 Yangtze River Pharmaceutical Agomelatine API Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Yangtze River Pharmaceutical Agomelatine API Product Portfolio
  18. 8.3.5 Yangtze River Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Agomelatine API Value Chain Analysis
  2. 9.1.1 Agomelatine API Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Agomelatine API Sales Mode & Process
  6. 9.2 Agomelatine API Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Agomelatine API Distributors
  9. 9.2.3 Agomelatine API Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst